Norges Bank
FLXN

Norges Bank’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Norges Bank’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,936
Closed -$208K – 2191
2020
Q3 		$208K Buy
+19,936
New +$244K ﹤0.01% 2118
2016
Q1 		– Sell
-25,900
Closed -$499K – 2214
2015
Q4 		$499K Sell
25,900
-24,100
-48% -$418K ﹤0.01% 2167
2015
Q3 		$743K Buy
+50,000
New +$1.17M ﹤0.01% 2151

Other funds holding FLXN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Norges Bank's FLXN Position: Q4 2020 in Review

Norges Bank sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2020, closing a stake of 19,936 shares — an estimated $208K sold.

Norges Bank first reported a position in FLXN in Q3 2015 and held it in 3 quarters. The position peaked at $743K in Q3 2015. 141 funds tracked by Wall St. Rank hold FLXN as of Q4 2020.

  • Norges Bank reported no remaining Flexion Therapeutics, Inc. position as of Q4 2020 after selling out during the quarter.
  • Norges Bank sold 19,936 Flexion Therapeutics, Inc. shares in Q4 2020, an estimated $208K.
  • Norges Bank first reported a position in Flexion Therapeutics, Inc. in Q3 2015 and held it in 3 quarters.
  • Norges Bank's Flexion Therapeutics, Inc. position peaked at $743K in Q3 2015.
  • 141 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2020.

Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.